© 2021 MJH Life Sciences and OncLive. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
January 04, 2021
Axel Grothey, MD, discusses the results of the phase 2 ANCHOR-CRC trial in patients with BRAF-mutant metastatic colorectal cancer.
December 22, 2020
Axel Grothey, MD, discusses the DESTINY-CRC01 trial in patients with HER2-positive colorectal cancer.
December 16, 2020
Axel Grothey, MD, discusses the role of precision medicine in colorectal cancer.
December 11, 2020
Axel Grothey, MD, discusses investigational combination therapies in microsatellite instability–high colorectal cancer.
October 22, 2020
Axel Grothey, MD, discusses combination therapies with regorafenib and trifluridine/tipiracil in colorectal cancer.
September 15, 2020
Noam VanderWalde, MD, MS, discusses the importance of implementing multidisciplinary care for patients with rectal cancer.